Biotech

All Articles

Takeda touches brand-new head of US oncology business-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our summary of significant management hirings, firings as...

Vertex, beaten by AATD once more, loses 2 resources on throw away pile

.Tip's effort to handle a rare hereditary ailment has attacked one more trouble. The biotech shook p...

Vir gains 3 T-cell engagers coming from Sanofi, gives up 25% of workers

.Vir Biotechnology's second-quarter earnings file wasn't short of significant news. The business inv...

Galapagos pauses CAR-T cell treatment trial over Parkinsonism case

.Galapagos has actually stopped briefly application in a trial of a BCMA-directed CAR-T tissue treat...

James Wilson leaving behind Penn to introduce pair of new biotechs

.After greater than 30 years, genetics treatment trailblazer James Wilson M.D., Ph.D., is actually l...

3 biotechs make an effort to trump the summer warmth by shedding team

.As biotechs attempt to switch a new web page in August, at least 3 providers have actually lost tea...

venBio elevates $528M for 5th life scientific researches VC fund

.Pro venture capital organization venBio has elevated yet another half a billion dollars to purchase...

Otsuka pays $800M for Jnana and also its clinical-stage PKU medication

.Otsuka Drug has gotten Boston-based Jnana Therapies for $800 thousand so the Eastern biotech may ac...

FibroGen lays off 75% people personnel as resource flunks 2 even more trials

.FibroGen is actually drastically reorganizing its company, giving up 75% of its own U.S. team as we...

Tracon winds down full weeks after injectable PD-L1 inhibitor fail

.Tracon Pharmaceuticals has chosen to wane procedures full weeks after an injectable invulnerable ga...